Lucid Diagnostics Inc
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
LUCD$0.42+4.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, 2023 | December 31, 2022 | |
|---|---|---|
| Assets: | ||
| Current assets: | ||
| Cash | $18,896 | $22,474 |
| Accounts receivable | 45 | 17 |
| Inventory | 278 | 111 |
| Prepaid expenses, deposits, and other current assets | 2,854 | 1,754 |
| Total current assets | 22,073 | 24,356 |
| Fixed assets, net | 1,334 | 1,592 |
| Operating lease right-of-use assets | 1,307 | 2,008 |
| Intangible assets, net | 1,424 | 3,445 |
| Other assets | 1,132 | 1,108 |
| Total assets | $27,270 | $32,509 |
| Liabilities, Preferred Stock and Stockholders’ Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable | $1,146 | $1,056 |
| Accrued expenses and other current liabilities | 3,841 | 1,447 |
| Operating lease liabilities, current portion | 1,106 | 962 |
| Senior Secured Convertible Note - at fair value | 13,950 | — |
| Due To: PAVmed Inc. - MSA Fee and operating expenses | 9,339 | 4,960 |
| Total current liabilities | 29,382 | 8,425 |
| Operating lease liabilities, less current portion | 199 | 1,037 |
| Total liabilities | 29,581 | 9,462 |
| Commitments and contingencies | - | - |
| Stockholders’ Equity: | ||
| Preferred stock, $0.001 par value, 20,000,000 shares authorized; Series A and Series A-1 Convertible Preferred Stock, issued and outstanding 18,625 at December 31, 2023 and no shares issued and outstanding at December 31, 2022 | 18,625 | — |
| Common stock, $0.001 par value, 200,000,000 shares authorized; 42,329,864 and 40,518,792 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | 42 | 41 |
| Additional paid-in capital | 129,763 | 121,081 |
| Accumulated deficit | (150,741) | (98,075) |
| Total Stockholders’ Equity (Deficit) | (2,311) | 23,047 |
| Total Liabilities and Stockholders’ Equity (Deficit) | $27,270 | $32,509 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.